UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging

American Journal of Neuroradiology, 2007-06, Vol.28 (6), p.1078-1084

2007

Volltextzugriff (PDF)

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

International journal of radiation oncology, biology, physics, 1999-02, Vol.43 (3), p.549-558

1999

Volltextzugriff (PDF)

Second cancers following pediatric Hodgkin's disease

Journal of clinical oncology, 1998-02, Vol.16 (2), p.536-544

1998

Volltextzugriff (PDF)

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme

International journal of radiation oncology, biology, physics, 1998-01, Vol.40 (2), p.287-295

1998

Volltextzugriff (PDF)

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas : Initial outcome and long-term results

The journal of clinical endocrinology and metabolism, 1998-10, Vol.83 (10), p.3411-3418

1998

Volltextzugriff (PDF)

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

Neuro-oncology (Charlottesville, Va.), 2004-07, Vol.6 (3), p.227-235

2004

Volltextzugriff (PDF)

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (3), p.1122-1128

2001

Volltextzugriff (PDF)

Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control

International journal of radiation oncology, biology, physics, 1997-01, Vol.37 (2), p.375-383

1997

Volltextzugriff (PDF)

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

Cancer, 1999-07, Vol.86 (2), p.331-339

1999

Volltextzugriff (PDF)

Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (20), p.7683-7688

2001

Volltextzugriff (PDF)

Relationship between pattern of enhancement and local control of brain metastases after radiosurgery

International journal of radiation oncology, biology, physics, 2001-05, Vol.50 (1), p.139-146

2001

Volltextzugriff (PDF)

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

Neuro-oncology (Charlottesville, Va.), 2014-04, Vol.16 (4), p.567-578

2014

Volltextzugriff (PDF)

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Neuro-oncology (Charlottesville, Va.), 2010-01, Vol.12 (1), p.95-103

2010

Volltextzugriff (PDF)

Radiosurgery for brain metastases from primary lung carcinoma

The cancer journal (Sudbury, Mass.), 2001-03, Vol.7 (2), p.121

2001

Volltextzugriff (PDF)

Radiation response and survival time in patients with glioblastoma multiforme

Journal of neurosurgery, 1996-03, Vol.84 (3), p.442-448

1996

Volltextzugriff (PDF)

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

Neuro-oncology (Charlottesville, Va.), 2010-08, Vol.12 (8), p.855-861

2010

Volltextzugriff (PDF)

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1511-1518

2012

Volltextzugriff (PDF)

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3246-3256

1998

Volltextzugriff (PDF)

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

Transplantation, 1998-07, Vol.66 (1), p.29

1998

Volltextzugriff (PDF)

Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results

Neurosurgery, 1999-02, Vol.44 (2), p.254-261

1999

Volltextzugriff (PDF)

Increased survival associated with radiolabeled lym‐1 therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia

Cancer, 1997-12, Vol.80 (S12), p.2706-2711

1997

Volltextzugriff (PDF)

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Neuro-oncology (Charlottesville, Va.), 2011-10, Vol.13 (10), p.1118-1124

2011

Volltextzugriff (PDF)

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

Neuro-oncology (Charlottesville, Va.), 2010-02, Vol.12 (2), p.164-172

2010

Volltextzugriff (PDF)

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (5), p.1805-1809

2001

Volltextzugriff (PDF)

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Neuro-oncology (Charlottesville, Va.), 2011-12, Vol.13 (12), p.1331-1338

2011

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(159)

Sprache

Englisch
(159)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(158)
Male
(135)
Science & Technology
(135)
Life Sciences & Biomedicine
(133)
Adult
(124)
Middle Aged
(121)
Aged
(97)
Oncology
(84)
Biological And Medical Sciences
(79)
Medical Sciences
(78)
Adolescent
(51)
Neurosciences & Neurology
(48)
Clinical Neurology
(47)
Treatment Outcome
(39)
Neurology
(37)
Brain Neoplasms - Drug Therapy
(33)
Brain Neoplasms - Mortality
(32)
Retrospective Studies
(32)
Tumors Of The Nervous System. Phacomatoses
(32)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

Second cancers following pediatric Hodgkin's disease

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas : Initial outcome and long-term results

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients

Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival

Relationship between pattern of enhancement and local control of brain metastases after radiosurgery

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Radiosurgery for brain metastases from primary lung carcinoma

Radiation response and survival time in patients with glioblastoma multiforme

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results

Increased survival associated with radiolabeled lym‐1 therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Aktive Filter

Suchergebnisse filtern